Literature DB >> 24268829

Haemophilus influenzae serotype a as a cause of serious invasive infections.

Marina Ulanova1, Raymond S W Tsang2.   

Abstract

Haemophilus influenzae, particularly H influenzae serotype b (Hib), is an important pathogen that causes serious diseases like meningitis and septicaemia. Since the introduction of Hib conjugate vaccines in the 1990s, the epidemiology of invasive H influenzae disease has changed substantially, with most infections now caused by non-Hib strains. We discuss the importance of H influenzae serotype a (Hia) as a cause of serious morbidity and mortality and its global epidemiology, clinical presentation, microbiology, immunology, prevention, and control. Much like Hib, the capsule of Hia is an important virulence factor contributing to the development of invasive disease. Molecular typing of Hia has identified distinct clonal groups, with some linked to severe disease and high case-fatality rates. Similarities between Hia and Hib capsules, their clinical presentation, and immunology of infection suggest that a bivalent Hia-Hib capsular polysaccharide-protein conjugate vaccine could offer protection against these two important serotypes of H influenzae.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24268829     DOI: 10.1016/S1473-3099(13)70170-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  40 in total

1.  Invasive Haemophilus influenzae Serotype a Infection in Children: Clinical Description of an Emerging Pathogen-Alaska, 2002-2014.

Authors:  Ian D Plumb; K Danielle Lecy; Rosalyn Singleton; Michael C Engel; Matthew Hirschfeld; James W Keck; Joseph Klejka; Karen M Rudolph; Thomas W Hennessy; Michael G Bruce
Journal:  Pediatr Infect Dis J       Date:  2018-04       Impact factor: 2.129

2.  Blood-Brain Barrier in a Haemophilus influenzae Type a In Vitro Infection: Role of Adenosine Receptors A2A and A2B.

Authors:  N Caporarello; M Olivieri; M Cristaldi; M Scalia; M A Toscano; C Genovese; A Addamo; M Salmeri; G Lupo; C D Anfuso
Journal:  Mol Neurobiol       Date:  2017-09-18       Impact factor: 5.590

3.  Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease-United States, 2009-2015.

Authors:  Heidi M Soeters; Amy Blain; Tracy Pondo; Brooke Doman; Monica M Farley; Lee H Harrison; Ruth Lynfield; Lisa Miller; Susan Petit; Arthur Reingold; William Schaffner; Ann Thomas; Shelley M Zansky; Xin Wang; Elizabeth C Briere
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

Review 4.  Risk Factors for Drug-Resistant Cap in Immunocompetent Patients.

Authors:  Francisco Arancibia; Mauricio Ruiz
Journal:  Curr Infect Dis Rep       Date:  2017-03       Impact factor: 3.725

5.  Cross-reactivity of Haemophilus influenzae type a and b polysaccharides: molecular modeling and conjugate immunogenicity studies.

Authors:  Nicole I Richardson; Michelle M Kuttel; Frank St Michael; Chantelle Cairns; Andrew D Cox; Neil Ravenscroft
Journal:  Glycoconj J       Date:  2021-09-07       Impact factor: 2.916

6.  Collaboration on a public health-driven vaccine initiative.

Authors:  S Desai; R Tsang; M St Laurent; A Cox
Journal:  Can Commun Dis Rep       Date:  2014-10-16

7.  The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action.

Authors:  L Barreto; A D Cox; M Ulanova; M G Bruce; Rsw Tsang
Journal:  Can Commun Dis Rep       Date:  2017-05-04

Review 8.  Long Term Impact of Conjugate Vaccines on Haemophilus influenzae Meningitis: Narrative Review.

Authors:  Mary Paulina Elizabeth Slack
Journal:  Microorganisms       Date:  2021-04-21

9.  Characterisation of invasive clinical Haemophilus influenzae isolates in Queensland, Australia using whole-genome sequencing.

Authors:  M Staples; R M A Graham; A V Jennison
Journal:  Epidemiol Infect       Date:  2017-03-06       Impact factor: 4.434

Review 10.  Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use.

Authors:  M P E Slack; A W Cripps; K Grimwood; G A Mackenzie; M Ulanova
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.